v3.22.2.2
Stockholders' Equity and Equity Incentive Plans (Tables)
 9 Months Ended
Oct. 31, 2022
Equity [Abstract]  
Share-based Payment Arrangement, Option, Activity
The following table is a summary of option activity during the nine months ended October 31, 2022:
Number of
Shares		Weighted Average
Exercise Price		Weighted Average Remaining Contractual TermAggregate
Intrinsic Value
(in thousands)(years)(in thousands)
Balance at January 31, 2022
15,928 $4.20 5.9$123,382 
Options granted— $— 
Options exercised(3,213)$3.53 
Options cancelled(1,000)$9.15 
Balance at October 31, 2022
11,715 $3.96 5.0$48,225 
Options exercisable at October 31, 2022
10,969 $3.63 4.9$44,709 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
The following table is a summary of RSU activity for the nine months ended October 31, 2022:
Number of
Shares		Weighted Average Grant Date Fair Value per Share
(in thousands)
Balance at January 31, 2022
9,502 $17.20 
Granted(a)
11,661 $8.80 
Released(2,369)$15.72 
Forfeited (2,769)$15.25 
Balance at October 31, 2022
16,025 $11.65 
RSUs expected to vest at October 31, 2022
16,025 $11.65 
______________
(a)Includes 1,023,797 awards subject to both service-based and performance-based vesting conditions based on a 100% attainment rate.
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table presents total stock-based compensation expense included in the condensed consolidated statements of operations (in thousands):
Three Months Ended October 31,Nine Months Ended October 31,
2022202120222021
Cost of revenue$418 $191 $1,092 $520 
Research and development(a)
7,511 6,441 21,606 16,957 
Sales and marketing5,237 3,749 13,871 11,393 
General and administrative4,551 2,556 13,364 10,257 
Total stock-based compensation expense$17,717 $12,937 $49,933 $39,127 
________________
(a)During the three and nine months ended October 31, 2022, the Company capitalized stock-based compensation of $0.1 million and $0.3 million related to internal-use software development costs, respectively. During the three and nine months ended October 31, 2021, the Company did not capitalize any stock-based compensation related to internal-use software development costs. The research and development stock-based compensation amounts are presented net of the capitalized costs.